Publications by authors named "Xiongyuan Jin"

Background: No data on the safety and efficacy of a live attenuated influenza vaccine in China have ever been reported.

Methods: At a site of a phase 3 randomized, double-blind, placebo-controlled clinical trial in eastern China, eligible healthy children aged 3-17 years underwent randomization to receive live attenuated vaccine or placebo at a ratio of 1:1. The primary objective of the study was the prevention of laboratory-confirmed influenza illness during the surveillance period, starting on day 15 after vaccination.

View Article and Find Full Text PDF